Attitudes of Internal Medicine Faculty and Residents Toward Professional Interaction With Pharmaceutical Sales Representatives

JAMA: The Journal of the American Medical Association

Volumn 264, Issue 13, 1990, Pages 1693-1697

  Mckinney, W Paul ^a,f   Schiedermayer, David L ^a   Lurie, Nicole ^b   Simpson, Deborah E ^a   Goodman, Jesse L ^c   Rich, Eugene C ^d,e  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d REGIONS HOSPITAL   (United States)

^e UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INFORMATION; DRUG MARKETING; INTERNAL MEDICINE; MEDICAL ETHICS; MEDICAL SPECIALIST; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RESIDENT;

ADULT; ATTITUDE OF HEALTH PERSONNEL; DRUG INDUSTRY; ETHICS, MEDICAL; FACULTY, MEDICAL; FEMALE; HUMAN; INTERNAL MEDICINE; INTERNSHIP AND RESIDENCY; INTERPROFESSIONAL RELATIONS; MALE; MIDDLE AGE; QUESTIONNAIRES; SUPPORT, NON-U.S. GOV'T;

EID: 0025005747     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1990.03450130065028     Document Type: Article

References (31)

1. 1. Lexchin J. Pharmaceutical promotion in Canada: convince them or confuse them. Int J Health Serv. 1987;17:77-89.
2. 2. Getting good value from drug reps. Drug Ther Bull. 1983;21:13-15.
3. 3. Connelly DP, Rich EC, Curley SP, Kelley JT. Knowledge resource preferences of family physicians. J Fam Pract. 1990;30:353-359.
4. 4. Eaton G, Parish P. General practitioners’ views of information about drugs. J R Coll Gen Pract. 1976;26(suppl):64-68.
5. 5. Eaton G, Parish P. Sources of drug information used by general practitioners. J R Coll Gen Pract. 1976;26(suppl):58-64.
6. 6. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8.
7. 7. Worthen DB. Prescribing influences: an overview. Br J Med Educ. 1973;7:109-117.
8. 8. Caplow T, Raymond JJ. Factors influencing the selection of pharmaceutical products. J Marketing. 1954;19:18-23.
9. 9. Goldfinger SE. A matter of influence. N Engl J Med. 1987;316:1408-1409.
10. 10. Musher DM. Antibiotics: the medium is the message. Rev Infect Dis. 1983;5:809-812.
11. 11. Musher DM, Young EJ, Hamill RJ. The ethics of pharmaceutical promotion. N Engl J Med. 1986; 315:590.
12. 12. Miller K, Gouveia WA, Barza M, et al. Undesirable marketing practices in the pharmaceutical industry. N Engl J Med. 1985;313:54.
13. 13. Graves J. Frequent flyer programs for drug prescribing. N Engl J Med. 1987;317:252.
14. 14. Schiedermayer DL, McKinney WP. The Feldene connection: drug dealing in the doctors’ parking lot? N Engl J Med. 1988;319:1291-1292.
15. 15. Wein PJ, Hoffman RP. What really sells a drug today? Hosp Pharm. 1988;23:478-479.
16. 16. Stross JK. Information sources and clinical decisions. J Gen Intern Med. 1987;2:155-159.
17. 17. Lurie N, Rich EC, Simpson DE, et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med. 1990;5:240-243.
18. 18. Messick S. Validity. In: Linn RL, ed. Educational Measurement. 3rd ed. New York, NY: Macmillan Publishing Co Inc; 1989:chap 1.
19. 19. Anastasi A. Psychological Testing. 4th ed. New York, NY: Macmillan Publishing Co Inc; 1976:153-154.
20. 20. Opren scandal. Lancet. 1983;1:219-220. Editorial.
21. 21. Chren MM, Landefeld S, Murray TH. Doctors, drug companies, and gifts. JAMA. 1989;262:3448-3451.
22. 22. Wikes M, Shuchman M. Pitching doctors. N Y Times Magazine. November 5, 1989:88.
23. 23. Royal College of Physicians. The relationship between physicians and the pharmaceutical industry. J R Coll Phys Lond. 1986;20:235-242.
24. 24. American College of Physicians. Physicians and the pharmaceutical industry. Ann Intern Med. 1990;112:624-626.
25. 25. Shaughnessy AF. Drug promotion in a family medicine training center. JAMA. 1988;260:926.
26. 26. Palmisano P, Edelstein J. Teaching drug promotion abuses to health profession students. J Med Educ. 1980;55:453-455.
27. 27. Ferguson RP. Training the resident to meet the detail men. JAMA. 1989;261:992-993.
28. 28. Phillips DJ, Smith JE. Hospital-based training for pharmaceutical manufacturers’ representatives. Am J Hosp Pharm. 1983;40:1661-1663.
29. 29. Willcox GS, Mahoney CD, Jeffrey LP. Monitoring the hospital activities of medical service representatives. Am J Hosp Pharm. 1983;40:989-991.
30. 30. Massengill R, Verghese A, Robert T. Course for drug representatives. J Med Educ. 1983;58:86.
31. 31. Powell SH, Stempien MJ, Vogenberg FR. Hospital-based training for pharmaceutical manufacturers’ representatives. Am J Hosp Pharm. 1984; 41:70-74.